NeuroPace Raises $67 Million Financing to Support Commercial Expansion of the RNSĀ® System for Refractory Epilepsy
08.31.20
MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–NeuroPace, Inc., a Silicon Valley-based medical technology company, today announced it has raised $67 million in a funding round led by Accelmed Partners with participation from an unnamed strategic investor…
This website uses cookies to collect information in connection with your use of this website. By continuing to use this website, you agree to the use of all of our cookies, which includes new versus returning visitors and country location only. We do not collect personal information. Terms and Conditions